HPV vaccination before pregnancy linked to lower risk of preterm birth and other major complications
A large Swedish study published in The BMJ suggests that receiving the HPV vaccine before pregnancy is linked to a lower risk of preterm birth and other major pregnancy complications. The benefits appear to be more pronounced in women who are vaccinated at a younger age.
Why it matters
This research provides evidence that HPV vaccination may offer protective health benefits for pregnancy outcomes beyond its primary role in cancer prevention.
edited by Sadie Harley , reviewed by Robert Egan
This article has been reviewed according to Science X's editorial process and policies . Editors have highlighted the following attributes while ensuring the content's credibility:
Add to Preferred Sources Credit: Amina Filkins from Pexels Receiving the human papillomavirus (HPV) vaccine before pregnancy is associated with a lower risk of major pregnancy complications, including preterm birth, with a greater reduction in risk seen among women vaccinated at an earlier age, according to a large Swedish study published by The BMJ .
The findings suggest that the benefits of HPV vaccination may extend beyond cancer prevention to reducing adverse pregnancy outcomes, say the researchers.
Get smarter about the news
Sign up free for a feed built around what you actually care about, Dive Deeper research on any story, and the full text of every article.
Create free accountAlready have an account? Sign in